Milestone Historical Cash Flow

MLSS Stock

USD 0.89 0.01 1.11%

Analysis of Milestone Scientific cash flow over time is an excellent tool to project Milestone Scientific future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 4.6 K or End Period Cash Flow of 3.4 M as it is a great indicator of Milestone Scientific ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Milestone Scientific latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Milestone Scientific is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.

About Milestone Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Milestone balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Milestone's non-liquid assets can be easily converted into cash.

Milestone Scientific Cash Flow Chart

At this time, Milestone Scientific's Cash And Cash Equivalents Changes is comparatively stable compared to the past year. Cash Flows Other Operating is likely to gain to about 1.9 M in 2024, despite the fact that Change In Cash is likely to grow to (5.5 M).

Begin Period Cash Flow Depreciation Capital Expenditures End Period Cash Flow Total Cash From Financing Activities

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Depreciation

Depreciation indicates how much of Milestone Scientific value has been used up. For tax purposes Milestone Scientific can deduct the cost of the tangible assets it purchases as business expenses. However, Milestone Scientific must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Capital Expenditures

Capital Expenditures are funds used by Milestone Scientific to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Milestone Scientific operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most accounts from Milestone Scientific's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Milestone Scientific current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.At this time, Milestone Scientific's Cash And Cash Equivalents Changes is comparatively stable compared to the past year. Cash Flows Other Operating is likely to gain to about 1.9 M in 2024, despite the fact that Change In Cash is likely to grow to (5.5 M).

Milestone Scientific cash flow statement Correlations

	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Capital Expenditures	Net Income	End Period Cash Flow	Sale Purchase Of Stock	Change To Liabilities	Change To Account Receivables	Stock Based Compensation	Change Receivables	Cash And Cash Equivalents Changes	Cash Flows Other Operating	Change To Netincome	Investments	Net Borrowings	Change To Operating Activities
Change To Inventory		-0.03	0.33	0.85	-0.15	0.58	0.12	0.24	-0.04	-0.19	-0.45	0.46	-0.09	-0.52	-0.34	-0.42	-0.16	-0.24	0.56	0.34	0.22
Change In Cash	-0.03		0.13	-0.02	-0.54	-0.17	-0.04	0.11	0.22	0.51	0.01	-0.53	0.18	-0.12	0.31	0.14	-0.14	-0.07	0.42	0.15	0.36
Free Cash Flow	0.33	0.13		0.47	-0.62	0.14	-0.46	0.38	0.81	-0.49	-0.76	0.13	-0.1	-0.66	-0.26	-0.6	-0.75	-0.22	0.1	-0.06	0.87
Change In Working Capital	0.85	-0.02	0.47		-0.17	0.65	0.21	0.4	-0.05	-0.18	-0.45	0.61	-0.07	-0.59	-0.17	-0.38	-0.22	-0.02	0.46	0.3	0.31
Begin Period Cash Flow	-0.15	-0.54	-0.62	-0.17		-0.16	0.15	-0.22	-0.58	0.45	0.63	0.21	0.05	0.63	0.25	0.48	0.55	0.18	-0.31	-0.32	-0.8
Depreciation	0.58	-0.17	0.14	0.65	-0.16		0.4	0.21	-0.3	-0.34	-0.32	0.66	-0.29	-0.47	-0.34	-0.32	0.02	0.02	0.25	0.47	-0.02
Other Non Cash Items	0.12	-0.04	-0.46	0.21	0.15	0.4		-0.31	-0.78	0.11	0.14	0.09	-0.08	-0.09	-0.09	0.02	0.61	0.64	0.14	0.54	-0.48
Capital Expenditures	0.24	0.11	0.38	0.4	-0.22	0.21	-0.31		0.3	-0.1	-0.44	0.38	0.03	-0.33	-0.11	-0.4	-0.67	-0.28	-0.03	0.22	0.42
Net Income	-0.04	0.22	0.81	-0.05	-0.58	-0.3	-0.78	0.3		-0.36	-0.54	-0.25	0.02	-0.34	-0.13	-0.37	-0.78	-0.47	-0.02	-0.31	0.84
End Period Cash Flow	-0.19	0.51	-0.49	-0.18	0.45	-0.34	0.11	-0.1	-0.36		0.65	-0.35	0.25	0.52	0.58	0.64	0.41	0.11	0.13	-0.17	-0.43
Sale Purchase Of Stock	-0.45	0.01	-0.76	-0.45	0.63	-0.32	0.14	-0.44	-0.54	0.65		-0.26	0.39	0.69	0.76	0.96	0.76	0.09	-0.17	-0.47	-0.67
Change To Liabilities	0.46	-0.53	0.13	0.61	0.21	0.66	0.09	0.38	-0.25	-0.35	-0.26		-0.46	-0.19	-0.35	-0.31	-0.21	0.02	-0.02	0.17	-0.1
Change To Account Receivables	-0.09	0.18	-0.1	-0.07	0.05	-0.29	-0.08	0.03	0.02	0.25	0.39	-0.46		-0.13	0.67	0.48	0.24	-0.09	-0.06	-0.31	0.14
Stock Based Compensation	-0.52	-0.12	-0.66	-0.59	0.63	-0.47	-0.09	-0.33	-0.34	0.52	0.69	-0.19	-0.13		0.31	0.58	0.45	-0.03	-0.18	-0.32	-0.69
Change Receivables	-0.34	0.31	-0.26	-0.17	0.25	-0.34	-0.09	-0.11	-0.13	0.58	0.76	-0.35	0.67	0.31		0.87	0.43	-0.11	-0.04	-0.63	-0.11
Cash And Cash Equivalents Changes	-0.42	0.14	-0.6	-0.38	0.48	-0.32	0.02	-0.4	-0.37	0.64	0.96	-0.31	0.48	0.58	0.87		0.66	-0.05	-0.05	-0.6	-0.46
Cash Flows Other Operating	-0.16	-0.14	-0.75	-0.22	0.55	0.02	0.61	-0.67	-0.78	0.41	0.76	-0.21	0.24	0.45	0.43	0.66		0.36	-0.07	-0.07	-0.78
Change To Netincome	-0.24	-0.07	-0.22	-0.02	0.18	0.02	0.64	-0.28	-0.47	0.11	0.09	0.02	-0.09	-0.03	-0.11	-0.05	0.36		-0.38	0.42	-0.38
Investments	0.56	0.42	0.1	0.46	-0.31	0.25	0.14	-0.03	-0.02	0.13	-0.17	-0.02	-0.06	-0.18	-0.04	-0.05	-0.07	-0.38		0.17	0.27
Net Borrowings	0.34	0.15	-0.06	0.3	-0.32	0.47	0.54	0.22	-0.31	-0.17	-0.47	0.17	-0.31	-0.32	-0.63	-0.6	-0.07	0.42	0.17		-0.08
Change To Operating Activities	0.22	0.36	0.87	0.31	-0.8	-0.02	-0.48	0.42	0.84	-0.43	-0.67	-0.1	0.14	-0.69	-0.11	-0.46	-0.78	-0.38	0.27	-0.08

Click cells to compare fundamentals

Milestone Scientific Account Relationship Matchups

Milestone Scientific cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	300.5K	(799.7K)	878.7K	(833.1K)	(1.1M)	(1.0M)
Change In Cash	772.8K	12.7M	540.4K	(6.0M)	(5.7M)	(5.5M)
Free Cash Flow	(1.8M)	(7.0M)	(4.0M)	(6.0M)	(5.3M)	(5.6M)
Change In Working Capital	1.8M	(1.8M)	1.1M	(549.7K)	(1.4M)	(1.3M)
Begin Period Cash Flow	743.4K	1.5M	14.2M	14.8M	8.7M	9.2M
Other Cashflows From Financing Activities	337.5K	19.4M	4.6M	(8.5K)	(3.0M)	(2.8M)
Depreciation	256.5K	95.9K	73.8K	144.4K	150.4K	209.7K
Other Non Cash Items	3.6M	1.7M	652.8K	1.3M	968.2K	739.5K
Capital Expenditures	9.9K	21.4K	15.2K	8.5K	4.9K	4.6K
Total Cash From Operating Activities	(1.8M)	(7.0M)	(4.0M)	(6.0M)	(5.3M)	(5.1M)
Net Income	(7.6M)	(7.4M)	(6.9M)	(8.8M)	(6.9M)	(7.3M)
End Period Cash Flow	1.5M	14.2M	14.8M	8.7M	3.0M	3.4M
Total Cash From Financing Activities	2.6M	19.7M	4.6M	(8.5K)	2.6M	2.8M
Sale Purchase Of Stock	213.3K	(250K)	2.6M	19.4M	22.4M	23.5M
Change To Liabilities	1.5M	290.4K	(1.9M)	308.2K	277.4K	374.1K
Change To Account Receivables	367.8K	630.0K	137.4K	249.6K	309.9K	325.4K
Stock Based Compensation	183.9K	1.3M	1.6M	1.8M	1.9M	1.1M
Change Receivables	269.7K	(587.1K)	296.9K	938.2K	1.1M	1.1M
Total Cashflows From Investing Activities	(15.4K)	(9.9K)	(21.4K)	(15.2K)	(17.5K)	(18.3K)
Cash And Cash Equivalents Changes	(965.3K)	(1.9M)	772.8K	12.7M	14.6M	15.3M
Cash Flows Other Operating	(643.6K)	1.2M	1.1M	1.5M	1.8M	1.9M
Change To Netincome	2.2M	3.7M	2.1M	1.7M	1.9M	2.1M
Investments	(9.9K)	(21.4K)	(15.2K)	(8.5K)	(2.5M)	(2.3M)
Change To Operating Activities	391.2K	1.2M	227.7K	(257.2K)	(231.5K)	(219.9K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Milestone Historical Cash Flow

About Milestone Cash Flow Analysis

Milestone Scientific Cash Flow Chart

Begin Period Cash Flow

Depreciation

Capital Expenditures

Milestone Scientific cash flow statement Correlations

Milestone Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Milestone Scientific cash flow statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Milestone Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Cash Equivalents Changes	+ 0.96	Sale Purchase Of Stock
Change To Operating Activities	+ 0.87	Free Cash Flow
Cash And Cash Equivalents Changes	+ 0.87	Change Receivables
Change In Working Capital	+ 0.85	Change To Inventory
Change To Operating Activities	+ 0.84	Net Income
Net Income	+ 0.81	Free Cash Flow

Change To Operating Activities	- 0.8	Begin Period Cash Flow
Change To Operating Activities	- 0.78	Cash Flows Other Operating
Cash Flows Other Operating	- 0.78	Net Income
Net Income	- 0.78	Other Non Cash Items
Sale Purchase Of Stock	- 0.76	Free Cash Flow
Cash Flows Other Operating	- 0.75	Free Cash Flow